Single Blind Randomized Controlled Trial to Evaluate Ketorolac Injections for Upper Extremity Tendinopathy and Arthropathy

What this Trial Is About

Osteoarthritis and inflammatory conditions affecting the tendons and joints of the shoulder, elbow, hand, and wrist are common and can cause significant pain and disability. This research aims to evaluate and compare the effects of ketorolac and triamcinolone injections for treating tendinopathy or arthropathy in these upper extremity areas. These conditions often reduce strength and daily function, and current treatments focus on managing symptoms rather than curing the disease. Participants in this study will be randomly assigned to receive either a ketorolac injection, a non-steroidal anti-inflammatory drug that reduces inflammation, or a triamcinolone injection, a corticosteroid that decreases inflammation. Both injections will be given using standard techniques by the treating physician. The study lasts for 24 weeks, with an important follow-up visit scheduled 6 weeks after the injection to assess outcomes. During the study, participants will have their pain levels measured using a visual analog scale, along with assessments of function and strength through questionnaires and physical tests at baseline, 6 weeks, and 24 weeks. These include patient-reported outcome measures, hand function assessments, and grip strength tests. The study will monitor the effects of the injections to help understand how best to manage wrist and hand joint conditions conservatively.

Ketorolac in Upper Extremity Tendinopathy and Arthropathy